Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd.

4519

Pozycja w akcjach #353
Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company,... Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company, operating subsidiaries involved in the full lifecycle of drug development, from research and manufacturing to sales, import, and export, serving both Japanese and international markets. Its commercialized product portfolio spans several key therapeutic areas. These include a robust oncology offering with leading treatments like Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda. Additionally, it provides medications for bone health (e.g., Actemra, Edirol, Bonviva), renal conditions (such as Mircera and Oxarol), and neurological or other diverse ailments (including Hemlibra, CellCept, and Enspryng). Beyond its existing offerings, the company maintains an active research and development pipeline. This pipeline features multiple promising candidates targeting oncology, orthopedic and joint disorders, autoimmune diseases, kidney-related conditions, and various neurological or other health issues. Strategic partnerships are central to Chugai's operations, most notably a significant alliance with the Roche Group. The company also fosters collaborative research initiatives with academic institutions. Established in 1925, Chugai's headquarters are located in Tokyo, Japan, and it operates as a key subsidiary of Roche Holding Ltd.
Cena akcji
$41.34
Kapitalizacja rynkowa
$68.04B
Zmiana (1 dzień)
0.05%
Zmiana (1 rok)
-12.50%
Kraj
JP
Handel Chugai Pharmaceutical Co., Ltd. (4519)

Kategoria

Healthcare
Historia podziałów akcji dla Chugai Pharmaceutical Co., Ltd. (4519)
Akcje Chugai Pharmaceutical Co., Ltd. (symbol: 4519) przeszły łącznie 0 podziałów.
Najnowszy podział miał miejsce Oct 20, 2026.
Jedna akcja 4519 kupiona przed Oct 20, 2026 odpowiada dziś 0 akcjom 4519.
Lista podziałów akcji
Rok Podział Mnożnik Skumulowany mnożnik
Za mało danych dla podanych dat.
Podziały akcji dla podobnych firm lub konkurencji
Firma Liczba podziałów akcji Skumulowany mnożnik Kraj
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 4 x15
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7 x432
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 0 -
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7 x226
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 2 x10000
CH